Targeted DNA Modification as a Novel Glioma Therapy: Journey from Bench to Biotech to Pharma…to Bedside…
- Tracing the journey of a groundbreaking technology, targeted DNA modification, from its initial discovery at the research bench to its successful translation into a biotech platform
- Detailing the strategic and financial evolution of the technology, highlighting how it attracted investment and ultimately led to a significant acquisition by a major pharmaceutical company
- Examining the path forward for this therapy, exploring how a promising scientific concept, now backed by a major pharma’s resources, is being advanced from the lab to clinical development and ultimately, to the patient’s bedside